Kaynes Technology Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹26,130 Cr
- Book Value
- ₹708.73
- Stock P/E
- 71.4
- Dividend Yield
- 0.00%
- ROE
- 9.64%
- ROCE
- 13.2%
- PEG Ratio
- 1.26
- EV/EBITDA
- 35.9
Fundamentals from Screener.in, as of 6 Aug 2026. Live price via Yahoo Finance.
Kaynes Technology share price today
Kaynes Technology India Ltd (NSE: KAYNES) was valued at ₹26,130 Cr in Gale’s internal 6 August 2026 research snapshot. The recorded share price was ₹3,856.30, compared with a 52-week high of ₹7,593 and a low of ₹3,001. A decline of nearly half from the high can look dramatic, but price distance is not the same thing as valuation support. The live quote above moves with the market; the financial ratios below remain tied to the dated snapshot.
Kaynes is one of India’s fastest-growing listed electronics-manufacturing businesses. Five-year sales and profit compounded at 54% and 108% in the internal data, and FY26 revenue grew another 33%. Yet the same FY26 official presentation shows negative operating cash flow, working-capital days expanding and adjusted return ratios falling as the company raised and deployed capital. This is the essential debate: can a broad electronics platform turn exceptional order growth into per-share cash returns before its premium multiple contracts?
What Kaynes Technology actually builds
Kaynes provides end-to-end electronics system design and manufacturing. Its work spans printed circuit board assemblies, box-build products, design-led original design manufacturing and services for sectors including automotive, industrial, aerospace, defence, railways, medical and other high-reliability applications. It is also investing in high-density interconnect printed circuit boards and semiconductor assembly and test capabilities.
That breadth is more important than the label “EMS”. Low-complexity contract assembly competes heavily on cost and can earn thin margins. Design ownership, certification, small-batch high-mix manufacturing and long qualification cycles can create deeper customer relationships. Kaynes’ 16% operating margin in the internal snapshot suggests its current mix is not a plain commodity assembler. The question is whether returns stay attractive after the capital required for new factories, inventory and customer programmes.
| Platform component | FY26 / recent evidence | Economic question |
|---|---|---|
| Core electronics manufacturing | FY26 revenue ₹3,626.4 Cr, up 33.2% | Can scale continue without sacrificing margin or working capital? |
| Order book | ₹8,366.3 Cr at FY26 year-end | How much converts on schedule and at the quoted margin? |
| HDI PCB expansion | First unit guided toward operational readiness in 2026 | Will utilisation justify the heavy upfront capital? |
| OSAT / semiconductor packaging | Pilot and early commercial capability under development | Can qualification become repeat high-value production? |
| Design-led programmes | Exposure across high-reliability sectors | Does IP and engineering depth raise customer stickiness? |
The opportunity is substantial. India is localising electronics supply chains, global customers are diversifying production and sophisticated domestic programmes require certified suppliers. But a favourable policy theme does not guarantee attractive shareholder returns. Incentives can accelerate capacity creation across the industry, and too much capital chasing the same demand can eventually reduce pricing. Kaynes must demonstrate that engineering capability and customer qualification, not subsidy alone, explain its economics.
FY26 growth was strong; cash conversion was not
According to Kaynes’ official FY26 investor presentation, revenue increased from ₹2,722.0 Cr to ₹3,626.4 Cr, EBITDA rose 39.8% to ₹574.1 Cr, and EBITDA margin improved from 15.1% to 15.8%. Profit after tax grew 24% to ₹363.9 Cr, but PAT margin declined from 10.8% to 10.0%. That is a strong income-statement performance, though profit expanded more slowly than EBITDA.
The cash-flow statement tells a harder story. FY26 operating cash flow was negative ₹600.4 Cr as inventory and receivables absorbed funds. Investing cash flow was negative ₹1,505.2 Cr, while financing brought in ₹1,579.6 Cr. These numbers do not invalidate the growth plan—rapidly scaling manufacturers often build working capital and capacity ahead of revenue—but they mean the plan is being funded by capital providers rather than self-financed operating cash.
| FY26 consolidated measure | FY25 | FY26 | Reading |
|---|---|---|---|
| Revenue | ₹2,722.0 Cr | ₹3,626.4 Cr | Up 33.2%; rapid programme ramp-up |
| EBITDA | ₹410.7 Cr | ₹574.1 Cr | Up 39.8%; faster than sales |
| EBITDA margin | 15.1% | 15.8% | Moderate improvement despite expansion |
| PAT | ₹293.5 Cr | ₹363.9 Cr | Up 24%; below EBITDA growth |
| Adjusted ROE | 19.4% | 11.4% | Capital base expanded faster than earnings |
| Adjusted ROCE | 19.2% | 13.1% | New investment has not yet reached mature utilisation |
| Operating cash flow | Positive in FY25 | -₹600.4 Cr | Inventory and receivables absorbed substantial cash |
The fall in return ratios is central to valuation. Net worth rose from ₹2,837.3 Cr to ₹4,727.1 Cr. A larger equity base can temporarily depress ROE before plants ramp, but “temporarily” must eventually be supported by evidence. If earnings grow while returns stay near 10%, the business may be creating scale without proportional value per rupee of capital. If the new assets reach good utilisation and working capital normalises, today’s lower returns may represent an investment phase.
An order book is revenue visibility, not cash in the bank
The FY26 year-end order book was ₹8,366.3 Cr, up from ₹6,596.9 Cr. In the first quarter of FY27, the company reported an order book of ₹8,903.8 Cr, revenue growth of 40% and EBITDA growth of 31%. That continued top-line momentum is constructive. However, Q1 FY27 PAT fell 24% and PAT margin declined to 6.0% from 11.1%, illustrating why order value alone cannot determine shareholder outcomes.
Orders may be cancelled, rescheduled, repriced or require higher-than-expected inventory. Different programmes carry different material content, design contribution and margin. Revenue recognition also depends on customer approvals and supply availability. Investors should compare book-to-bill, conversion, gross margin and cash collection rather than simply divide the order book by annual revenue.
Customer concentration deserves attention. Kaynes disclosed that its top five customers represented about 46% of the order book, the top ten about 60% and the top twenty roughly 76%. High-reliability relationships can be sticky, but a delayed programme from one large customer can still shift quarterly economics. Diversification should be measured by revenue and gross profit, not the number of logos on a slide.
| Order-quality test | Constructive evidence | Warning evidence |
|---|---|---|
| Order conversion | Revenue follows schedule without large inventory build | Repeated deferments or rising unbilled work |
| Customer concentration | New programmes broaden gross-profit contribution | One account dominates incremental growth |
| Programme margin | Stable gross margin as volume scales | Revenue rises while PAT margin falls persistently |
| Collections | Receivable days stabilise or decline | Credit grows faster than customer shipments |
| Book-to-bill | Healthy replacement of delivered orders | Backlog relies on a few very long-dated projects |
Working capital is the crucial operating variable
Net working-capital days increased from 87 in FY25 to 125 in FY26. Inventory days rose from 84 to 134, receivable days from 91 to 97 and payable days from 88 to 106. Supplier credit partly funded the expansion, but not enough to offset inventory and customer credit. Electronics manufacturing requires component availability and programme-specific stock, especially when supply chains are uncertain. Even so, inventory that does not convert can become obsolete or require write-downs.
| Working-capital measure | FY25 | FY26 | Change |
|---|---|---|---|
| Inventory days | 84 | 134 | +50 days |
| Receivable days | 91 | 97 | +6 days |
| Payable days | 88 | 106 | +18 days |
| Net working-capital days | 87 | 125 | +38 days |
| FY26 operating cash flow | — | -₹600.4 Cr | Material cash absorption |
A credible normalisation would involve inventory days falling as new plants and programmes move from setup to repeat production, with customer collections keeping pace. Operating cash flow should eventually approach reported profit over a full cycle. Continued negative cash flow alongside headline growth would imply recurring funding needs and possible dilution. This distinction is why an EMS valuation should never be based on revenue CAGR alone.
PCB and OSAT projects expand the opportunity—and execution risk
Kaynes is moving upstream into HDI printed circuit boards and semiconductor assembly and test. Strategically, these capabilities can deepen localisation and increase the value captured per product. Operationally, they are different businesses with expensive equipment, yield-learning curves, certification needs and potentially long customer qualification. A slide announcing readiness is not the same as a factory producing at commercial yield.
Investors should follow project cost versus plan, commissioning date, qualified customers, utilisation, yield, incentive receipts and segment profitability. Early losses are not automatically a failure, but repeated changes to timelines or capital budgets weaken forecast confidence. The most attractive outcome is cross-selling: an existing design or box-build customer adopts locally made boards or packaging, reducing customer-acquisition risk. The least attractive outcome is parallel capacity that remains underused while depreciation and finance costs depress profit.
The OSAT opportunity is especially sensitive to technology and customer approval. Semiconductor packaging can earn better economics than basic assembly, but competition is global and the learning curve is unforgiving. The target scenarios therefore do not assume that every announced project succeeds. The base case uses growth below Kaynes’ recent three-year pace and a lower exit multiple than the snapshot P/E.
Growth, margins and capital efficiency
Gale’s internal snapshot records five-year sales CAGR of 54%, five-year profit CAGR of 108%, three-year sales CAGR of 48% and three-year profit CAGR of 57%. Those numbers justify serious attention but also create a difficult base. Hypergrowth naturally slows as revenue becomes larger, and market expectations may decline before business growth does.
| Internal operating evidence | 6 Aug 2026 snapshot | Interpretation |
|---|---|---|
| Sales CAGR, 5 years | 54% | Exceptional scale-up from a smaller base |
| Profit CAGR, 5 years | 108% | Strong operating leverage, partly base-sensitive |
| Sales CAGR, 3 years | 48% | Momentum remained rapid entering FY26 |
| Profit CAGR, 3 years | 57% | Earnings outpaced sales over the recent period |
| Operating margin | 16% | Higher-value mix than commodity assembly |
| ROCE | 13.2% | Below the growth rate and below mature premium expectations |
| ROE / five-year ROE | 9.64% / 11% | Capital accumulation has diluted current returns |
The mismatch between growth and returns is not a contradiction; it is the result of timing and capital intensity. Kaynes has raised funds and invested ahead of capacity utilisation. For shareholders, the critical question is whether the numerator catches up with the denominator. Revenue and profit must eventually rise faster than capital employed, while free cash flow turns positive after maintenance and growth investment.
Balance sheet and ownership
The internal debt-to-equity ratio was 0.19, promoter holding 53.46% and promoter pledge zero. Kaynes’ official presentation showed FY26 net debt of ₹207.4 Cr, down from ₹581.3 Cr after the equity raise, and adjusted net debt/equity near zero. This provides financing flexibility, but it should not be mistaken for cash self-sufficiency: external equity strengthened the balance sheet while operations consumed cash.
| Balance-sheet check | Dated evidence | What it means |
|---|---|---|
| Debt/equity | 0.19 | Modest financial leverage in Gale’s snapshot |
| FY26 net debt | ₹207.4 Cr | Lower after fund-raising, before full project ramp |
| FY26 net worth | ₹4,727.1 Cr | Large capital base now needs productive deployment |
| Promoter holding | 53.46% | Meaningful ownership alignment |
| Promoter pledge | 0% | No pledge overhang in the snapshot |
| Dividend yield | 0% | Investment return depends on growth and valuation |
Future dilution, project debt and contingent commitments matter more than the current headline leverage ratio. Management should be judged on capital allocation across core EMS, PCB and OSAT rather than on the ambition of the combined addressable market.
The numbers
| Metric | Internal 6 Aug 2026 snapshot |
|---|---|
| Market capitalisation | ₹26,130 Cr |
| Snapshot price | ₹3,856.30 |
| P/E · price/book | 71.4× · 5.50× |
| PEG · EV/EBITDA | 1.26 · 35.9× |
| ROE · ROCE | 9.64% · 13.2% |
| Operating margin | 16% |
| Debt/equity | 0.19 |
| EPS (TTM) | ₹54.59 |
| Book value per share | ₹708.73 |
| 52-week range | ₹3,001 – ₹7,593 |
Valuation: growth must become cash return
At 71.4 times TTM earnings and 35.9 times EV/EBITDA in the internal snapshot, Kaynes was priced for years of strong execution even after the share-price decline. Price/book of 5.5 times sits against ROE below 10%, a combination that only works if returns improve materially. PEG of 1.26 looks less demanding because historical growth was very high, but a backward-looking growth denominator is especially dangerous for a capital-intensive hypergrowth company.
The scenario model uses the exact internal TTM EPS of ₹54.59 dated 6 August 2026. It compounds EPS for the 147 days remaining to the 2026 year-end, adds one full year for each later row, and applies the stated exit P/E, with every displayed outcome rounded to the nearest ₹5. The exit multiples are below the snapshot P/E, explicitly allowing valuation to normalise as the company becomes larger. Even the bull case requires proof through earnings and cash, not only an order-book announcement.
| Scenario | EPS growth assumption | Exit P/E | What the case assumes |
|---|---|---|---|
| Bear | 15% | 34× | Growth slows, working capital stays heavy and the premium compresses |
| Base | 24% | 48× | Core programmes convert while new capacity ramps with manageable friction |
| Bull | 33% | 62× | EMS, PCB and OSAT execute together and capital returns improve |
Kaynes Technology share price target 2026 to 2030
The table below is a sensitivity range, not a promised destination. It links the same TTM EPS base to clearly disclosed growth and P/E assumptions for each year, so readers can see how much of the outcome comes from operations and how much comes from market valuation.
Scenario warning: order conversion, customer concentration, component availability, working capital, project commissioning, dilution and market multiples can differ substantially from these assumptions. No scenario is personal investment advice.
What would change our view
The case would improve if net working-capital days declined, operating cash flow turned positive across a full year, new plants met commissioning and yield milestones, and adjusted ROCE recovered as capital was utilised. A growing order book would then be supported by cash evidence rather than standing alone.
The case would weaken if inventory continued to compound faster than revenue, customer programmes were repeatedly delayed, PCB or OSAT costs exceeded plans, PAT margins remained under pressure or another large equity raise was needed before current projects produced cash. A governance, qualification or quality failure would be more serious than a normal quarterly demand fluctuation.
| Review item | Present concern | Evidence of progress |
|---|---|---|
| Operating cash flow | FY26 was materially negative | Positive cash generation after working capital |
| Inventory days | Increased sharply | Decline without missed deliveries |
| Adjusted ROCE | Fell during investment phase | Improvement as new assets generate profit |
| Order conversion | Backlog is large | Revenue, margin and collection track together |
| PCB / OSAT execution | Capital and technology risk | Commissioning, qualification, yield and utilisation |
| Customer concentration | Top accounts remain important | Broader gross-profit contribution |
Should you buy Kaynes Technology at the current price?
Kaynes offers genuine exposure to electronics localisation and has executed exceptional growth. The dated valuation, however, still gives little credit for delays, cash absorption or lower returns on newly raised capital. A large fall from a previous high is not a substitute for a margin of safety.
Investors considering the share should decide how much evidence they require from operating cash flow and project ramp-up before paying a premium. Existing holders should track capital productivity, not only quarterly revenue. Gale’s signed-in panel shows its current classification, while the paid section contains the accumulation band; those tools do not replace suitability, diversification or professional advice.
FAQ
What is the Kaynes Technology share price target for 2030?
The signed-in table shows bear, base and bull outcomes for 2026–2030. Each follows the disclosed EPS-growth and exit-P/E inputs, so there is no single guaranteed target.
Why is Kaynes Technology’s order book important?
It provides visibility into potential future manufacturing work, but it is not the same as revenue or cash. Conversion schedule, programme margin, customer acceptance, inventory and collection determine its economic value.
Why was Kaynes’ FY26 operating cash flow negative?
Inventory and receivables expanded during rapid programme and capacity growth. The key test is whether that investment reverses into cash as orders convert, rather than becoming a permanent funding requirement.
What are Kaynes’ PCB and OSAT opportunities?
They can move the company into higher-value parts of the electronics chain and deepen localisation. They also require substantial capital, technical yields and customer qualification, so commercial milestones matter more than planned capacity alone.
What is the biggest valuation risk?
Earnings growth can remain positive while the share disappoints if cash conversion stays weak or the P/E multiple normalises. A growth slowdown and multiple compression can happen simultaneously.
When are Kaynes Technology’s next results?
Consult Gale’s results calendar and verify the date in Kaynes’ exchange disclosure. The company filing is the authoritative source for any schedule change.
Related research
- Dixon Technologies share price target
- Netweb Technologies share price target
- HBL Engineering share price target
Sources and methodology
- Kaynes FY26 earnings release and FY26 investor presentation.
- Kaynes Q1 FY27 earnings release and Q1 FY27 investor presentation, used only as post-FY26 evidence.
- Screener.in consolidated financials, captured in Gale’s approved internal research snapshot on 6 August 2026.
Live quote data is indicative and separate from the fixed 6 August fundamentals. Company presentation metrics retain management’s definitions; Gale’s valuation model uses the internal TTM EPS shown above.
This article is research and education, not personalised investment advice. Gale is not a SEBI-registered investment adviser. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.